Interview with AdAlta (ASX:1AD) CEO Dr. Tim Oldham

July 22, 2021

1AD, AdAlta, Tim Oldham, video

Summary

We talked to AdAlta CEO Dr. Tim Oldham about the conversion of the lead I-body product AD-214 to nebulised delivery and about the major upside from the GE Healthcare collaboration.

 

Stocks Down Under … Serious research for the serious investor!

 

Get Marc & Stuart’s Top Picks

Improve your investment skills with our Investor Webinars

Learn about ASX-listed stocks with our 4 editions per week across all sectors

Get access to everything with a 30-day FREE TRIAL.

No credit card required!

 

GET A 30-DAY FREE TRIAL